Full Press Release Details
Pharmaceuticals to Present at the 2016 Rodman & Renshaw 18th
Global Investment Conference
VICTORIA, British Columbia--(BUSINESS WIRE)--September 7, 2016--Aurinia
Pharmaceuticals Inc., (NASDAQ: AUPH / TSX:AUP) today announced that its
Chief Operating Officer, Michael R. Martin, will present a corporate
overview of the Company at the 2016 Rodman & Renshaw 18th Annual Global
Investment Conference, taking place September 11th-13th
at the Lotte New York Palace Hotel in New York City. The presentation
will also be available via webcast at the link listed below.
Aurinia Presentation Details
| Date: | Monday, September 12 th , 2016 | |
| Time: | 10:00 a.m. Eastern time | |
| Location: | Lotte New York Palace Hotel, Louis Room (4 th floor) | |
| Webcast: | http://wsw.com/webcast/rrshq26/auph |
Aurinia is a clinical stage
biopharmaceutical company focused on developing and commercializing
therapies to treat targeted patient populations that are suffering from
serious diseases with a high unmet medical need. The company is
headquartered in Victoria, BC and focuses its development efforts
Visit www.auriniapharma.com for more information.
Investor & Media Contact:
VP, Investor Relations